Arvind Kaul

2.2k total citations · 1 hit paper
37 papers, 1.4k citations indexed

About

Arvind Kaul is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Arvind Kaul has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 8 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Arvind Kaul's work include Systemic Lupus Erythematosus Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Vasculitis and related conditions (4 papers). Arvind Kaul is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Vasculitis and related conditions (4 papers). Arvind Kaul collaborates with scholars based in United Kingdom, United States and Canada. Arvind Kaul's co-authors include Graham Hughes, Zahi Touma, Ronald van Vollenhoven, Guillermo Ruiz‐Irastorza, Murray B. Urowitz, Mary K. Crow, Caroline Gordon, Nidhi Sofat, Nicholas R. Fuggle and Toby O. Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Arvind Kaul

32 papers receiving 1.4k citations

Hit Papers

Systemic lupus erythematosus 2016 2026 2019 2022 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvind Kaul United Kingdom 10 761 568 195 184 134 37 1.4k
Rosaria Talarico Italy 26 986 1.3× 298 0.5× 243 1.2× 89 0.5× 54 0.4× 108 2.0k
H J Haga Norway 22 583 0.8× 385 0.7× 245 1.3× 104 0.6× 44 0.3× 35 1.2k
G. Kollerup Denmark 22 538 0.7× 195 0.3× 263 1.3× 82 0.4× 137 1.0× 43 1.7k
Laura González-López Mexico 25 927 1.2× 410 0.7× 285 1.5× 99 0.5× 32 0.2× 120 1.8k
Antonio Carletto Italy 22 797 1.0× 620 1.1× 312 1.6× 112 0.6× 41 0.3× 133 2.0k
Hèctor Corominas Spain 21 628 0.8× 174 0.3× 147 0.8× 103 0.6× 35 0.3× 168 1.4k
Piotr Wiland Poland 28 1.1k 1.4× 1.1k 1.9× 345 1.8× 247 1.3× 41 0.3× 152 2.6k
Jorge Iván Gámez-Nava Mexico 25 916 1.2× 388 0.7× 259 1.3× 95 0.5× 27 0.2× 107 1.8k
José María Pego‐Reigosa Spain 22 959 1.3× 503 0.9× 138 0.7× 165 0.9× 23 0.2× 82 1.6k
Nurhan Sutcliffe United Kingdom 21 645 0.8× 308 0.5× 77 0.4× 79 0.4× 123 0.9× 43 1.3k

Countries citing papers authored by Arvind Kaul

Since Specialization
Citations

This map shows the geographic impact of Arvind Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Kaul more than expected).

Fields of papers citing papers by Arvind Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Kaul. The network helps show where Arvind Kaul may publish in the future.

Co-authorship network of co-authors of Arvind Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Kaul. A scholar is included among the top collaborators of Arvind Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Kaul. Arvind Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pollak, Thomas, Efthalia Massou, Felix Naughton, et al.. (2025). Self-reported cognitive dysfunction and memory impairment in Systemic Autoimmune Rheumatic Diseases (SARDs): a mixed methods analysis of the INSPIRE cohort. Lara D. Veeken. 64(12). 6213–6223. 1 indexed citations
2.
Piper, Martha, et al.. (2025). “My world has shrunk”: a mixed-methods exploration of the impact of systemic autoimmune rheumatic diseases on patients’ lives. Rheumatology International. 45(11). 247–247. 1 indexed citations
3.
Kaul, Arvind, et al.. (2025). VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms. The Lancet Rheumatology. 7(10). e719–e733.
4.
Kaul, Arvind, et al.. (2024). OA03 Idiopathic recurrent pericarditis treated with anakinra: an autoinflammatory phenomenon?. Rheumatology Advances in Practice. 8(Supplement_1).
5.
Savage, L., et al.. (2023). Collaboration in the management of psoriasis and psoriatic arthritis: A survey of joint working in UK clinical practice. SHILAP Revista de lepidopterología. 2(3). 559–565. 1 indexed citations
6.
Kaul, Arvind, Ali Jawad, & Graham Hughes. (2023). Antiphospholipid syndrome, thrombosis and multidisciplinary management. Trends in Urology & Men s Health. 14(3). 31–35.
7.
Kaul, Arvind, et al.. (2022). Lingual Raynaud’s phenomenon: a rare presentation. BMJ Case Reports. 15(11). e251988–e251988.
8.
Feltz‐Cornelis, Christina M. van der, Mark J. Edwards, Nicholas Gall, et al.. (2022). Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership. BMJ Open. 12(7). e061263–e061263. 8 indexed citations
9.
Kaul, Arvind, et al.. (2022). Tocilizumab for relapsing and remitting giant cell arteritis: a case series. Journal of Medical Case Reports. 16(1). 389–389.
11.
Feltz‐Cornelis, Christina M. van der, et al.. (2020). IL-6 and hsCRP in Somatic Symptom Disorders and related disorders. Brain Behavior & Immunity - Health. 9. 100176–100176. 14 indexed citations
12.
Kaul, Arvind, Caroline Gordon, Mary K. Crow, et al.. (2016). Systemic lupus erythematosus. Nature Reviews Disease Primers. 2(1). 16039–16039. 849 indexed citations breakdown →
13.
Adamson, Rosemary, Shirish Sangle, Arvind Kaul, Graham Hughes, & David D’Cruz. (2008). Clinical Improvement in Antiphospholipid Syndrome After Rituximab Therapy. JCR Journal of Clinical Rheumatology. 14(6). 359–360. 22 indexed citations
14.
15.
Collis, Rachel, Peter W. Collins, Arvind Kaul, et al.. (1994). The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Medicine. 20(1). 37–41. 86 indexed citations
16.
Abbot, Stewart, Arvind Kaul, Clifford R. Stevens, & David R. Blake. (1992). Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression. Arthritis & Rheumatism. 35(4). 401–406. 64 indexed citations
17.
Kaul, Arvind, David R. Blake, & J.D. Pearson. (1991). Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis.. Annals of the Rheumatic Diseases. 50(11). 828–832. 8 indexed citations
18.
Kaul, Arvind, et al.. (1991). Vascular endothelium: A potential role in hiv infection and the pathogenesis of kaposi's sarcoma: Observations and speculations. Molecular Aspects of Medicine. 12(4). 297–312. 3 indexed citations
19.
Osathanondh, Rapin, Burton V. Caldwell, Arvind Kaul, et al.. (1985). Efficacy of fenoprofen in the treatment of primary dysmenorrhea.. PubMed. 30(12). 915–9. 6 indexed citations
20.
Kaul, Arvind, et al.. (1966). [Bilateral giant cell arteritis with skin necrosis in the temporal region].. PubMed. 17(3). 126–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026